• Financial Information for the Year Ended March 31, 2021 [PDF:495KB]
• FY2020 Business Results (Presentation) [PDF:886KB]

For Mitsubishi Chemical Holdings(MCHC) Group's IR information, visit MCHC's website.

• Medium-Term Management Plan 21-25 (Presentation) [PDF:2,255KB]
• Transcript [PDF:207KB]

For Mitsubishi Chemical Holdings(MCHC) Group's analysts meeting materials, visit MCHC's website.

• Financial Information for the 3rd Quarter of Fiscal Year Ending March 31, 2021 [PDF:491KB]
• Q3 FY2020 Business Results (Presentation) [PDF:1,036KB]

For Mitsubishi Chemical Holdings(MCHC) Group's IR information, visit MCHC's website.

• Financial Information for the 2nd Quarter of Fiscal Year Ending March 31, 2021 [PDF:602KB]
• Q2 FY2020 Business Results (Presentation) [PDF:994KB]

For Mitsubishi Chemical Holdings(MCHC) Group's IR information, visit MCHC's website.

• Financial Information for the 1st Quarter of Fiscal Year Ending March 31, 2021 [PDF:417KB]
• Q1 FY2020 Business Results (Presentation) [PDF:1,015KB]

For Mitsubishi Chemical Holdings(MCHC) Group's IR information, visit MCHC's website.

• Financial Information for the Year Ended March 31, 2020 [PDF:607KB]
• FY2019 Business Results (Presentation) [PDF:900KB]

For Mitsubishi Chemical Holdings(MCHC) Group's IR information, visit MCHC's website.

• Financial Results for the First Nine Months of the Fiscal year ending March 31, 2020 [PDF:1.1MB]
• Conference Call<Presentation:Business Results> [PDF:1.5MB]
• Transcript (Q&A session included) [PDF:4.6MB]
• On-demand replay (Q&A session included)

• Financial Results for the First Six Months of the Fiscal year ending March 31, 2020 [PDF:264KB]
• Supplement [PDF:565KB]
• Conference Call<Presentation:Business Results> [PDF:1.6MB]
• Transcript (Q&A session included) [PDF:1.8MB]
• On-demand replay (Q&A session included)

• Presentation [PDF:2.1MB]
• Transcript (Opinion Sharing/Q&A session included) [PDF:4.84MB]
• On-demand replay (Opinion Sharing/Q&A session included)

• Financial Results for the First Three Months of the Fiscal year ending March 31, 2020 [PDF:1MB]
• Conference Call<Presentation:Business Results> [PDF:412KB]
• Transcript (Q&A session included) [PDF:998KB]
• On-demand replay (Q&A session included)

• Financial Results for the Fiscal Year ended March 31, 2019 [PDF:390KB]
• Supplement [PDF:400KB]
• Presentation<FY2018 Business Results> [PDF:2.4MB]
• Transcript (Q&A session included) [PDF:1.7MB]
• On-demand replay of the IR meeting (Q&A session included)

• Conference Call<Presentation:Revision to Consolidated Financial Forecasts for FY2018> [PDF:174KB]
• Transcript of Conference Call (Q&A session included) [PDF:2.4MB]
• On-demand replay of Conference Call (Q&A session included)

• Financial Results for the First Nine Months of the Fiscal year ending March 31, 2019 [PDF:1.1MB]
• Conference Call<Presentation:Business Results> [PDF:396KB]
• Transcript of Conference Call (Q&A session included) [PDF:1.1MB]
• On-demand replay of Conference Call (Q&A session included)

• Presentation [PDF:1.7MB]
• On-demand replay of the IR meeting (Q&A session included)

• Financial Results for the First Six Months of the Fiscal year ending March 31, 2019 [PDF:262KB]
• Supplement [PDF:399KB]
• Conference Call<Presentation:Business Results> [PDF:2.2MB]
• On-demand replay of Conference Call (Q&A session included)

• Financial Results for the First Three Months of the Fiscal year ending March 31, 2019 [PDF:2.8MB]
• Conference Call<Presentation:Business Results> [PDF:1.5MB]

• Financial Results for year ended March 31, 2018 [PDF:355KB]
• Supplement [PDF:818KB]
• Presentation<FY2017 Business Results> [PDF:2.1MB]

• Financial Results for the First Nine Months of the Fiscal year ending March 31, 2018 [PDF:864KB]
• Conference Call<Presentation:Business Results> [PDF:1.2MB]

• Presentation<Open Up the Future> [PDF:2.9MB]

• Financial Results for the First Six Months of the Fiscal year ending March 31, 2018 [PDF:228KB]
• Supplement [PDF:467KB]
• Conference Call<Presentation:Business Results> [PDF:1.8MB]

• Presentation<Vaccine business Strategy> [PDF:3.55MB]

• Financial Results for the First Three Months of the Fiscal year ending March 31, 2018 [PDF:969KB]
• Conference Call<Presentation:Business Results> [PDF:1.1MB]

• Presentation<Mitsubishi Tanabe Pharma to acquire NeuroDerm Ltd.> [PDF:1.68MB]

• Financial Results for year ended March 31, 2017 [PDF:993KB]
• Supplement [PDF:595KB]
• Notice of Dividend of Retained Earnings [PDF:96KB]
• Presentation<FY2016 Business Results> [PDF:1.9MB]

• Summary of 3rd Quarter Financial Results for year ending March 31, 2017 [PDF:1.1MB]
• Conference Call<Presentation:Business Results> [PDF:1.1MB]

• Presentation<Open Up the Future> [PDF:2.6MB]

• Summary of 2nd Quarter Financial Results for year ending March 31, 2017 [PDF:940KB]
• Supplement [PDF:266KB]
• Conference Call<Presentation:Business Results> [PDF:1.65MB]

• Summary of 1st Quarter Financial Results for year ending March 31, 2017 [PDF:1MB]
• Conference Call<Presentation:Business Results> [PDF:1MB]

• Summary of Financial Results for year ended March 31, 2016 [PDF:1.1MB]
• Supplement [PDF:524KB]
• Notice of Dividend of Retained Earnings [PDF:49KB]
• Presentation<FY2015 Business Results> [PDF:2.58MB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2016 [PDF:877KB]
• Conference Call<Presentation:Business Results> [PDF:1.18MB]
• Conference Call<Q&A> [PDF:73KB]

Presentation material

• <Medium-Term Management Plan 16-20: Open Up the Future> [PDF:1.41MB]
• Q&A [PDF:96KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2016 [PDF:764KB]
• Supplement [PDF:682KB]
• Conference Call<Presentation:Business Results> [PDF:1.8MB]
• Conference Call<Q&A> [PDF:152KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2016 [PDF:281KB]
• Conference Call<Presentation:Business Results> [PDF:749KB]
• Conference Call<Q&A> [PDF:50KB]

• Summary of Financial Results for year ended March 31, 2015 [PDF:420KB]
• Supplement [PDF:351KB]
• Notice of Dividend of Retained Earnings [PDF:70KB]
• Presentation<FY2014 Business Results> [PDF:1.60MB]
• Q&A [PDF:36KB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2015 [PDF:283KB]
• Conference Call<Presentation:Business Results> [PDF:833KB]
• Conference Call<Q&A> [PDF:47KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2015 [PDF:155KB]
• Supplement [PDF:301KB]
• Presentation<2nd Quarter of FY2014 Business Results> [PDF:1.14MB]
• Q&A [PDF:47KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2015 [PDF:272KB]
• Conference Call<Presentation:Business Results> [PDF:736KB]
• Conference Call<Q&A> [PDF:78KB]

• Summary of Financial Results for year ended March 31, 2014 [PDF:374KB]
• Supplement [PDF:309MB]
• Presentation<FY2013 Business Results> [PDF:1.73MB]
• Q&A [PDF:82KB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2014 [PDF:278KB]
• Conference Call<Presentation:Business Results> [PDF:472KB]
• Conference Call<Q&A> [PDF:42KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2014 [PDF:177KB]
• <Supplement [PDF:373KB]

Presentation

• <Business Results> [PDF:741KB]
• <Development Pipeline> [PDF:767KB]
• Q&A [PDF:44KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2014 [PDF:307KB]
• Conference Call<Presentation:Business Results> [PDF:486KB]
• Conference Call<Q&A> [PDF:42KB]

• Summary of Financial Results for year ended March 31, 2013 [PDF:394KB]
• Supplement [PDF:427KB]

Presentation

• <Business Performance> [PDF:836KB]
• <Development Pipeline> [PDF:695KB]
• Business Results Briefing<Q&A> [PDF:46KB]

Presentation

• <Becoming a “Company that Can Continue to Provide New Value”> [PDF:3.75MB]
• Information Meeting<Q&A> [PDF:95KB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2013 [PDF:333KB]
• Conference Call<Presentation:Business Results> [PDF:572KB]
• Conference Call<Q&A> [PDF:25KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2013 [PDF:548KB]
• Supplement [PDF:281KB]
• Conference Call<Presentation:Business Results> [PDF:655KB]
• Conference Call<Q&A> [PDF:24KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2013 [PDF:305KB]
• Conference Call<Presentation:Business Results> [PDF:210KB]
• Conference Call<Q&A> [PDF:43KB]

• Summary of Financial Results for year ended March 31, 2012 [PDF:437KB]
• Supplement [PDF:281KB]

Presentation

• <Business Performance> [PDF:358KB]
• <Sales Strategy for a Big Jump> [PDF:561KB]
• Business Results Briefing<Q&A> [PDF:45KB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2012 [PDF:285KB]
• Conference Call<Presentation:Business Results> [PDF:291KB]
• Conference Call<Q&A> [PDF:41KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2012 [PDF:230KB]
• Supplement [PDF:359KB]
• Conference Call<Presentation:Business Results> [PDF:353KB]
• Conference Call<Q&A> [PDF:64KB]

Presentation

• <Medium-Term Management Plan 11-15 ~New Value Creation> [PDF:3.84MB]
• Briefing<Q&A> [PDF:50KB]

• Presentation Material [PDF:1023KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2012 [PDF:300KB]
• Conference Call<Presentation:Business Results> [PDF:935KB]
• Conference Call<Q&A> [PDF:44KB]

• Summary of Financial Results for year ended March 31, 2011 [PDF:425KB]
• Supplement [PDF:435KB]

Presentation

• <Business Performance> [PDF:683KB]
• <Progress of the Development Pipeline> [PDF:674KB]
• Business Results Briefing<Q&A> [PDF:50KB]

• Summary of 3rd Quarter Financial Results for year ended March 31, 2011 [PDF:142KB]
• Conference Call<Presentation:Business Results Outline> [PDF:133KB]
• Conference Call<Q&A> [PDF:45KB]

• Presentation Material [PDF:599KB]
• R&D Meeting<Q&A> [PDF:23KB]

• Summary of 2nd Quarter Financial Results for year ended March 31, 2011 [PDF:79KB]
• Supplement [PDF:389KB]

Presentation

• <Business Performance> [PDF:241KB]
• <Product Strategy & Development Pipeline> [PDF:286KB]
• Business Results Briefing<Q&A> [PDF:45KB]

• Presentation Material [PDF:1302KB]

• Summary of 1st Quarter Financial Results for year ended March 31, 2011 [PDF:458KB]
• Conference Call<Presentation:Business Results Outline> [PDF:132KB]
• Conference Call<Q&A> [PDF:23KB]